Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charles Rudin

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 29, 2009
Cancer stem cellsCharles Rudin, John Minna
Viruses|April 30, 2021
N-Linked Glycosylation on Anthrax Toxin Receptor 1 Is Essential for Seneca Valley Virus InfectionNadishka Jayawardena, Linde A Miles, Laura N Burga, et al.
Endocrine-Related Cancer|February 28, 2021
Ribociclib and everolimus in well-differentiated foregut neuroendocrine tumorsNitya Raj, Youyun Zheng, Haley Hauser, et al.
The Oncologist|February 12, 2020
Eosinophilic Fasciitis Following Checkpoint Inhibitor Therapy: Four Cases and a Review of LiteratureKarmela Kim Chan, Cynthia Magro, Alexander Shoushtari, et al.
JAMA|May 22, 2014
Using multiplexed assays of oncogenic drivers in lung cancers to select targeted drugsMark G Kris, Bruce E Johnson, Lynne D Berry, et al.
European Journal of Cancer (Oxford, England : 1990)|September 16, 2019
Phase II randomised discontinuation trial of brivanib in patients with advanced solid tumoursRobin L Jones, Mark J Ratain, Peter J O'Dwyer, et al.
Cell|March 31, 2026
A convergent uPAR-positive tumor ecosystem creates broad vulnerability to CAR T cell therapyZeda Zhang, Yu-Jui Ho, Xin Fang, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 29, 2009
Cancer stem cellsCharles Rudin, John Minna
Viruses|April 30, 2021
N-Linked Glycosylation on Anthrax Toxin Receptor 1 Is Essential for Seneca Valley Virus InfectionNadishka Jayawardena, Linde A Miles, Laura N Burga, et al.
Endocrine-Related Cancer|February 28, 2021
Ribociclib and everolimus in well-differentiated foregut neuroendocrine tumorsNitya Raj, Youyun Zheng, Haley Hauser, et al.
The Oncologist|February 12, 2020
Eosinophilic Fasciitis Following Checkpoint Inhibitor Therapy: Four Cases and a Review of LiteratureKarmela Kim Chan, Cynthia Magro, Alexander Shoushtari, et al.
JAMA|May 22, 2014
Using multiplexed assays of oncogenic drivers in lung cancers to select targeted drugsMark G Kris, Bruce E Johnson, Lynne D Berry, et al.
European Journal of Cancer (Oxford, England : 1990)|September 16, 2019
Phase II randomised discontinuation trial of brivanib in patients with advanced solid tumoursRobin L Jones, Mark J Ratain, Peter J O'Dwyer, et al.
Cell|March 31, 2026
A convergent uPAR-positive tumor ecosystem creates broad vulnerability to CAR T cell therapyZeda Zhang, Yu-Jui Ho, Xin Fang, et al.
Pageof 1